Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

Nadia L Amin, MBChB, MSc, MA, Sally Kinsey, MD FRCP, FRCPath, Richard Feltbower, PhD MSc, BSc, Ajay J. Vora, Nicholas Goulden, MD PhD, Rachel Wade, MSc, Chris Mitchell, FRCPCH, Rachael Hough, MDBMBS,FRCP,FRCPath, Clare Rowntree, PhD, Beki James, PhD MBChB, MA

Blood (2015) 126 (23): 2083.

https://doi.org/10.1182/blood.V126.23.2083.2083

Published: 2015

Journal Articles

Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial

David O'Connor, MD PhD, Jack Bartram, MD, Amir Enshaei, PhD, Anthony V Moorman, PhD, Christine Harrison, PhDFRCPath FMedSci, Rachel Wade, MSc, Rachel Clack, MSc, Jeremy Hancock, PhD, Sujith Samarasinghe, MD PhD, John Moppett, MD PhD, Ajay J. Vora, Nicholas Goulden, MD PhD

Blood (2015) 126 (23): 1412.

https://doi.org/10.1182/blood.V126.23.1412.1412

Published: 2015

Journal Articles

Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:Â Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003

Jack Bartram, MD, David O'Connor, MD PhD, Amir Enshaei, PhD, Anthony V Moorman, PhD, Christine Harrison, PhDFRCPath FMedSci, Rachel Wade, MSc, Rachel Clack, MSc, Jeremy Hancock, PhD, Sujith Samarasinghe, MD PhD, John Moppett, MD PhD, Ajay J. Vora, Nicholas Goulden, MD PhD

Blood (2015) 126 (23): 806.

https://doi.org/10.1182/blood.V126.23.806.806

Published: 2015

Journal Articles

Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy

Amir Enshaei, PhD, Claire Schwab, Lucy Chilton, PhD, Rachel Wade, MSc, Jeremy Hancock, PhD, Christopher Mitchell, MBBS, PhD FRCP, Sally E Kinsey, Nicholas Goulden, MD PhD, Ajay J. Vora, Christine Harrison, PhDFRCPath FMedSci, Anthony V. Moorman, PhD

Blood (2015) 126 (23): 805.

https://doi.org/10.1182/blood.V126.23.805.805

Published: 2015

Journal Articles

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Katharine Patrick, FRCPath, Rachel Wade, MSc, Nicholas Goulden, Clare Rowntree, FRCPath, Rachael Hough, FRCPath, Christopher D Mitchell, FRCPCH, Ajay J Vora

Blood (2013) 122 (21): 56.

https://doi.org/10.1182/blood.V122.21.56.56

Published: 2013

Journal Articles

Prognostic Factors in the UK LRF CLL4 Trial.

David Graham Oscier, MD, Rachel Wade, MSc, Jenny Orchard, MD, Zadie Davis, MSc, Giles Best, PhD, Alison Morilla, BSc, Vasantha Brito-Bapapulle, PhD, Estella Matutes, MD, Sue Richards, DPhil, Daniel Catovsky, MD

Blood (2006) 108 (11): 299.

https://doi.org/10.1182/blood.V108.11.299.299

Published: 2006

NARROW

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial

Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:Â Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003

Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Prognostic Factors in the UK LRF CLL4 Trial.

Email alerts

ASH Publications

American Society of Hematology

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial

Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:Â Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003

Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Prognostic Factors in the UK LRF CLL4 Trial.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only